INOpulse
Showing 1 - 13 of 13
Pulmonary Fibrosis, Pulmonary Hypertension Trial (INOpulse)
Available
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse
- (no location specified)
Apr 26, 2022
Coronavirus Infection, COVID-19, Pneumonia, Viral Trial (iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System)
No longer available
- Coronavirus Infection
- +2 more
- iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System
- (no location specified)
Aug 9, 2022
Pulmonary Arterial Hypertension, Pulmonary Hypertension Trial in Canada, United States (Inhaled Nitric Oxide 0.025 mg/kg IBW/hr
Completed
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension
- Inhaled Nitric Oxide 0.025 mg/kg IBW/hr delivered via INOpulse DS Device
- +2 more
-
Birmingham, Alabama
- +50 more
Jul 13, 2022
Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via
Completed
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled NO delivered via INOpulse DS-C Device
- Placebo delivered via INOpulse DS-C Device
-
Jasper, Alabama
- +42 more
Jul 13, 2022
Pulmonary Fibrosis, Pulmonary Hypertension Trial in United States (INOpulse®, Placebo, Long Term Follow Up)
Active, not recruiting
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse®
- +2 more
-
Phoenix, Arizona
- +22 more
Feb 17, 2023
COVID-19, Hypoxemia, Hypoxemic Respiratory Failure Trial in Miami (Inhaled nitric oxide (iNO), Nitrogen gas, Oxygen gas)
Withdrawn
- COVID-19
- +2 more
- Inhaled nitric oxide (iNO)
- +2 more
-
Miami, FloridaUniversity of Miami Hospitals & Clinics
Aug 17, 2020
COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)
Terminated
- COPD
- +2 more
- Inhaled Nitric Oxide 30mcg/kg IBW/hr
-
Edegem, BelgiumAntwerp University Hospital
Aug 9, 2022
Pulmonary Fibrosis, Pulmonary Hypertension Trial in Canada, United States (INOpulse®, Placebo, Open Label Extension)
Active, not recruiting
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse®
- +2 more
-
Birmingham, Alabama
- +63 more
Jan 19, 2023
Pulmonary Arterial Hypertension Trial in Pittsburgh (Nitric Oxide)
Completed
- Pulmonary Arterial Hypertension
- Nitric Oxide
-
Pittsburgh, PennsylvaniaAllegheny General Hospital
Aug 24, 2018
Pulmonary Hypertension, COPD, Idiopathic Pulmonary Fibrosis Trial in Edegem (inhaled Nitric Oxide - 30 mcg/kg IBW/hr, inhaled
Completed
- Pulmonary Hypertension
- +2 more
- inhaled Nitric Oxide - 30 mcg/kg IBW/hr
- +2 more
-
Edegem, BelgiumAntwerp University Hospital
Aug 3, 2017
Pulmonary Hypertension, Lung Disease, Sickle Cell Disease Trial in Denver, Providence (Inhaled Nitric Oxide)
Terminated
- Pulmonary Hypertension
- +4 more
- Inhaled Nitric Oxide
-
Denver, Colorado
- +2 more
Sep 8, 2016
Malaria, Cerebral Trial in Mbarara (inhaled nitric oxide, Placebo)
Completed
- Malaria, Cerebral
- inhaled nitric oxide
- Placebo
-
Mbarara, UgandaMbarara Regional Referral Hospital
Feb 29, 2016
Coronary Disease, Myocardial Ischemia Trial run by the NHLBI (Nitric Oxide and INOpulse Delivery System)
Completed
- Coronary Disease
- Myocardial Ischemia
- Nitric Oxide and INOpulse Delivery System
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Mar 3, 2008